RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Newsroom

RTI’s Shaun McCullough recognized by Society of Toxicology for respiratory toxicity research

A paper by McCullough that will inform safer, more reliable toxicity assessments earned “Best Paper of the Year” plaudits


RESEARCH TRIANGLE PARK, N.C. — A paper by Shaun D. McCullough, Ph.D., a Senior Respiratory Scientist at the independent scientific research institute RTI International, has been named the “Best Paper of the Year” by the Society of Toxicology’s Regulatory and Safety Evaluation Specialty Section (RSESS). 

The recognition highlights his pivotal study, “Liquid application dosing alters the physiology of air-liquid interface (ALI) primary human bronchial epithelial cell/lung fibroblast co-cultures and in vitro testing relevant endpoints,” published in Frontiers in Toxicology in January 2024.

“I am honored to receive this recognition from the Society of Toxicology on behalf of my very talented and determined research team,” said McCullough. “Our findings described in the paper provide important insights on how new approach methodologies (NAMs) can be used to enable safer, more reliable toxicity assessments for industrial chemicals, consumer products, and air pollutants.”
 

Dr. McCullough (left) receives "Best Paper of the Year" honor from the Regulatory and Safety Evaluation Specialty Section at the 64th Annual Meeting of the Society of Toxicology (photo by Dr. Erin Huber)

Dr. McCullough (left) receives the "Best Paper of the Year" honor from the Regulatory and Safety Evaluation Specialty Section at the 64th Annual Meeting of the Society of Toxicology.

Photo credit: by Dr. Erin Huber

McCullough and his colleagues found that applying liquid to the surface of these air-liquid interface (ALI) cultures, which mimic in vivo conditions in the respiratory tract, can disrupt cell behavior even without any test substance. These disruptions can make cells from healthy donors exhibit disease-like behaviors that could limit their use for reliably predicting the effects of experimental exposures on human health during chemical safety testing.

The paper is the first characterization of a commonly-used method in early steps to gain acceptance of new approach methodologies (NAMs) as an alternative to animal testing in the assessment of potential respiratory toxicity for chemicals.

The findings directly support efforts by the Environmental Protection Agency (EPA) and Food and Drug Administration (FDA) to adopt NAMs for evaluating inhalable chemicals and pharmaceuticals.

Read the full paper (via Frontiers in Toxicology)

Learn more about RTI’s in vitro respiratory modeling and toxicity testing capabilities

RTI International is an independent, scientific research institute dedicated to improving the human condition. Our vision is to address the world's most critical problems with technical and science-based solutions in pursuit of a better future. Clients rely on us to answer questions that demand an objective and multidisciplinary approach—one that integrates expertise across social, statistical, data, and laboratory sciences, engineering, and other technical disciplines to solve the world’s most challenging problems. 

For more information, visit www.rti.org.